Articles
As one of the top two hair growth treatments projected to reach the market in 2018, Replicel’s RCH-01 has a lot of people’s attention these days. When it was announced that the global cosmetic company Shiseido would trial Replicel’s hair growth technology in Japan, there was also talk from Shiseido that the treatment could reach…
Read More
Almost two months ago, a reader of Follicle Thought sent me an interesting article about new research being done in hair growth. The article I received was from a Turkish news website regarding an innovative gene therapy. I’ve done a bit of research on the topic since then and now will share my findings. Novartis Studying…
Read More
According to its latest press release, Aclaris Therapeutics will be launching a phase 2 trial for the use of JAK inhibitors in androgenic alopecia (pattern hair loss) within the next few months. Here’s the line item from the press release about Aclaris’ trial in androgenic alopecia. AGA-201 Topical – a planned Phase 2 open-label clinical trial…
Read More
Healthcare Venture Award Presentation: Update (10/31/23) Fukuda’s company TrichoSeeds was selected as a finalist at the 5th Healthcare Venture Award event which took place in Tokyo, Japan on October 27, 2023. The event featured innovative biotechnology companies from Japan, especially those which focused on extending healthspan and longevity. Follicle Thought was fortunate to capture an…
Read More
Hi Everyone, this is a check-in to keep you abreast of what’s going on with the website and to announce a few hair-growth news items. Yokohama and Fries, Please First, I’m pleased to announce I have an exclusive update regarding the “french fry hair growth” craze which was clobbering headlines around the world for the…
Read More
One of the most interesting companies working on a cellular hair growth therapy, HairClone of the UK, has just released their first newsletter update of 2018. The contents of the newsletter have been divided into business updates and scientific updates for the company. One of the updates mentions a crowdfunding campaign video from HairClone and…
Read More
Stem cells and ‘the cure for hair loss.’ In our minds they go hand-in-hand, don’t they? Since the initial emergence of stem cell technologies in regenerative medicine, many have wondered if these technologies could be used to treat hair loss or alopecia. Today, many stem cell companies are developing technologies that would appear to make…
Read More
A lot has changed in the hair growth industry since I began Follicle Thought three years ago. Many new names and glimmers of hope have shown up in the industry. Even celebrity hair restoration has become more widespread and talked about. These are all positive developments which support the ultimate goal we are heading towards.…
Read More
Last week I had the opportunity to join a video conference with the HCell team to discuss their therapy aimed at multiple forms of alopecia. The HCell company emerged on the internet around mid January 2018 through the announcement of their Orphan Drug Designation from the FDA to treat pediatric alopecia areata. That press release…
Read More
An interesting bit of news was released by the company Follicum this morning. In conjunction with a specialized research company Dualsystems Biotech, Follicum has identified receptors in hair follicle cells that their lead drug candidate FOL-005 binds to. This represents a viable mechanism of action for their product. The press release mentions this information could…
Read More